XML 32 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
[2]
Preferred Stock Issuance
Common Stock Issuance
Preferred Stock
Preferred Stock
Preferred Stock Issuance
Common Stock
Common Stock
Common Stock Issuance
Additional Paid-in Capital
Additional Paid-in Capital
Common Stock Issuance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
[2]
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Treasury Stock
Common Stock Issuance
Beginning Balance at Dec. 31, 2017 $ 2,229,857       $ 0   $ 552,232   $ 1,478,389   $ 821,619   $ (32,974) $ (589,409)  
Beginning Balance (in shares) at Dec. 31, 2017         0   175,170                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net Income 208,393                   208,393        
Other comprehensive income (loss) (18,988)                       (18,988)    
Stock issued 6,735           $ 2,062   3,432         1,241  
Stock issued (in shares)             977                
Stock-based compensation awards 7,965           $ 83   7,882            
Stock-based compensation awards (in shares)             33                
Acquisition of treasury stock (95,308)                         (95,308)  
Acquisition of treasury stock (in shares)             (5,996)                
Reclassification of stranded tax effects 0                   7,101 [1]   (7,101) [1]    
Common stock cash dividends (91,081)                   (91,081)        
Ending Balance at Dec. 31, 2018 2,247,573       $ 0   $ 554,377   1,489,703   946,032   (59,063) (683,476)  
Ending Balance (in shares) at Dec. 31, 2018         0   170,184                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net Income 226,339                   226,339        
Other comprehensive income (loss) 58,926                       58,926    
Stock issued 6,362           $ 1,733   2,565         2,064  
Stock issued (in shares)             883                
Stock-based compensation awards 7,413               7,413            
Acquisition of treasury stock (111,457)                         (111,457)  
Acquisition of treasury stock (in shares)             (6,849)                
Common stock cash dividends (92,980)                   (92,980)        
Ending Balance at Dec. 31, 2019 2,342,176       $ 0   $ 556,110   1,499,681   1,079,391   (137) (792,869)  
Ending Balance (in shares) at Dec. 31, 2019         0   164,218                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net Income 178,040                   178,040        
Other comprehensive income (loss) 65,228                       65,228    
Stock issued     $ 192,878 $ 7,375   $ 192,878   $ 1,807   $ 907         $ 4,661
Stock issued (in shares)           200   1,040              
Stock-based compensation awards 7,529               7,529            
Acquisition of treasury stock (39,748)                         (39,748)  
Acquisition of treasury stock (in shares)             (2,908)                
Common stock cash dividends (90,708)                   (90,708)        
Preferred stock dividend (2,135)                   (2,135)        
Ending Balance at Dec. 31, 2020 $ 2,616,828 $ (43,807)     $ 192,878   $ 557,917   $ 1,508,117   $ 1,120,781 $ (43,807) $ 65,091 $ (827,956)  
Ending Balance (in shares) at Dec. 31, 2020         200   162,350                
[1] Result of adoption of ASU 2018-02. See Note 1 to Consolidated Financial Statements for further details.
[2] The Corporation adopted ASU 2016-13 "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments on January 1, 2020. See Note 1 to the Consolidated Financial Statements for further details.